Glycemic Index in Mitochondrial Disease
Acute Effects of Dietary Glycemic Index on Lactate and Glucose Homeostasis in Individuals With Primary Mitochondrial Disease
1 other identifier
observational
18
1 country
1
Brief Summary
The investigators are conducting a research study on nutrition in mitochondrial disease. The investigators are interested in the kind of carbohydrates that people eat. Carbohydrates are an important source of energy. Certain kinds of carbohydrates tend to raise blood sugar more in healthy people, and others tend to raise blood sugar less in healthy people. The investigators would like to know if by eating the "right" type of carbohydrate, people with mitochondrial disease can avoid high lactate levels, high blood sugar levels, and, later, low blood sugars. In this study, this question will be answered by finding out how people with mitochondrial disease respond to two different test meals containing different kinds of carbohydrates. Neither participants nor the investigators will know which kind of test meal participants are eating.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
October 21, 2014
CompletedFirst Posted
Study publicly available on registry
November 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedNovember 20, 2020
November 1, 2020
2 years
October 21, 2014
November 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
lactate area under the curve (AUC) for 3 hours after MMTT
within-subject change in lactate area under the curve (AUC) for 3 hours (low- vs. high- glycemic index)
visit 1 (baseline, 0 months), visit 2 (around 1 month)
Secondary Outcomes (4)
hypoglycemia (< 70 mg/dL) post-MMTT
visit 1 (baseline, 0 months), visit 2 (around 1 month)
glucose area under the curve (AUC) for 3 hours after MMTT
visit 1 (baseline, 0 months), visit 2 (around 1 month)
insulin area under the curve (AUC) for 3 hours after MMTT
visit 1 (baseline, 0 months), visit 2 (around 1 month)
combined index of attention (CPT-III) during MMTT
visit 1 (baseline, 0 months), visit 2 (around 1 month)
Study Arms (2)
Low GI-High GI
Two study visits are separate by around one month. For this arm, test meal (Visit 1): low-glycemic index; test meal (Visit 2): high-glycemic index
High GI-Low GI
Two study visits are separate by around one month. For this arm, test meal (Visit 1): high-glycemic index; test meal (Visit 2): low-glycemic index
Interventions
low- or high-glycemic index test meal, administered during mixed meal tolerance test
Eligibility Criteria
patients with mitochondrial diseases, from existing observational cohort study and/or CHOP Genetics/Metabolism clinic
You may qualify if:
- Weight \> 15 kg
- Girls ≥ 11 years of age and/or who have achieved menarche must have a negative urine pregnancy test.
- Genetic and/or biochemical diagnosis of mitochondrial disease.
- Eat meals by mouth during the day.
You may not qualify if:
- Diabetes requiring insulin.
- Receive daytime total parenteral nutrition (TPN) and/or continuous enteral feedings.
- Prescribed dietary contraindication to mixed meal tolerance testing, e.g., ketogenic diet.
- Any investigational drug use within 30 days prior to enrollment.
- Pregnant or lactating females.
- Persons unable to fast for at least 4 hours.
- Persons who may be allergic to the test meals (shakes).
- Parents/guardians or subjects who, in the opinion of the Investigator, may be non-adherent to study schedules or procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital of Philadelphialead
- University of Pennsylvaniacollaborator
Study Sites (1)
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Biospecimen
Blood samples obtained during MMTT.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2014
First Posted
November 6, 2014
Study Start
October 1, 2014
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
November 20, 2020
Record last verified: 2020-11